Investing.com -- Barclays warned that margin pressure could loom large over second-quarter U.S. earnings, with rising tariffs ...

Investing.com -- Markets may be inadvertently giving President Donald Trump the green light to escalate tariffs, according to ...

Capricor Therapeutics (NASDAQ:CAPR) stock plunged 53% after the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) rejecting its application for ...